Bank of New York Mellon’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-60,062
| Closed | -$3.17M | – | 4283 |
|
|
2020
Q3 | $3.17M | Sell |
60,062
-1,423
| -2% | -$87.8K | ﹤0.01% | 2434 |
|
|
2020
Q2 | $3.77M | Sell |
61,485
-5,113
| -8% | -$296K | ﹤0.01% | 2353 |
|
|
2020
Q1 | $3.77M | Sell |
66,598
-1,156
| -2% | -$65.9K | ﹤0.01% | 2220 |
|
|
2019
Q4 | $3.86M | Buy |
67,754
+2,232
| +3% | +$118K | ﹤0.01% | 2464 |
|
|
2019
Q3 | $3.51M | Buy |
65,522
+1,516
| +2% | +$88.3K | ﹤0.01% | 2454 |
|
|
2019
Q2 | $3.82M | Buy |
64,006
+3,028
| +5% | +$191K | ﹤0.01% | 2465 |
|
|
2019
Q1 | $3.8M | Sell |
60,978
-8,398
| -12% | -$556K | ﹤0.01% | 2460 |
|
|
2018
Q4 | $4.21M | Sell |
69,376
-875
| -1% | -$52.3K | ﹤0.01% | 2401 |
|
|
2018
Q3 | $4.11M | Buy |
70,251
+276
| +0.4% | +$14.1K | ﹤0.01% | 2495 |
|
|
2018
Q2 | $3.14M | Sell |
69,975
-501
| -0.7% | -$21.5K | ﹤0.01% | 2615 |
|
|
2018
Q1 | $3.12M | Buy |
70,476
+1,397
| +2% | +$58.7K | ﹤0.01% | 2582 |
|
|
2017
Q4 | $2.99M | Buy |
69,079
+755
| +1% | +$33.9K | ﹤0.01% | 2610 |
|
|
2017
Q3 | $3.18M | Buy |
68,324
+260
| +0.4% | +$12.4K | ﹤0.01% | 2557 |
|
|
2017
Q2 | $3.37M | Buy |
68,064
+643
| +1% | +$33.7K | ﹤0.01% | 2536 |
|
|
2017
Q1 | $3.69M | Buy |
67,421
+3
| +0% | +$159 | ﹤0.01% | 2485 |
|
|
2016
Q4 | $3.76M | Buy |
67,418
+1,512
| +2% | +$72.7K | ﹤0.01% | 2482 |
|
|
2016
Q3 | $3.01M | Sell |
65,906
-535
| -0.8% | -$21.5K | ﹤0.01% | 2514 |
|
|
2016
Q2 | $2.65M | Buy |
66,441
+2,063
| +3% | +$75.6K | ﹤0.01% | 2552 |
|
|
2016
Q1 | $2.24M | Sell |
64,378
-13,220
| -17% | -$485K | ﹤0.01% | 2588 |
|
|
2015
Q4 | $3.33M | Buy |
77,598
+4,916
| +7% | +$246K | ﹤0.01% | 2417 |
|
|
2015
Q3 | $3.17M | Buy |
72,682
+9,456
| +15% | +$510K | ﹤0.01% | 2480 |
|
|
2015
Q2 | $3.26M | Buy |
63,226
+3,230
| +5% | +$138K | ﹤0.01% | 2610 |
|
|
2015
Q1 | $2.35M | Buy |
59,996
+16,173
| +37% | +$634K | ﹤0.01% | 2750 |
|
|
2014
Q4 | $1.69M | Sell |
43,823
-34
| -0.1% | -$1.3K | ﹤0.01% | 2978 |
|
|
2014
Q3 | $1.55M | Buy |
43,857
+4,114
| +10% | +$121K | ﹤0.01% | 3046 |
|
|
2014
Q2 | $1.07M | Buy |
39,743
+12,117
| +44% | +$316K | ﹤0.01% | 3273 |
|
|
2014
Q1 | $716K | Buy |
27,626
+965
| +4% | +$23.1K | ﹤0.01% | 3439 |
|
|
2013
Q4 | $578K | Buy |
26,661
+14,760
| +124% | +$302K | ﹤0.01% | 3530 |
|
|
2013
Q3 | $232K | Buy |
+11,901
| New | +$211K | ﹤0.01% | 3758 |
|
Other funds holding BSTC
Bank of New York Mellon's BSTC Position: Q4 2020 in Review
Bank of New York Mellon sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 60,062 shares — an estimated $3.17M sold.
Bank of New York Mellon first reported a position in BSTC in Q3 2013 and held it in 29 quarters. The position peaked at $4.21M in Q4 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Bank of New York Mellon reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Bank of New York Mellon sold 60,062 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $3.17M.
- Bank of New York Mellon first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 29 quarters.
- Bank of New York Mellon's BioSpecifics Technologies Corp. position peaked at $4.21M in Q4 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Bank of New York Mellon's 13F filing for Q4 2020, filed 9 Feb 2021.